1416 Results

People

  1. Motzer
    Motzer
  2. Vickers
    Vickers
  3. Hudis
    Hudis
  4. Norton
    Norton
  5. Saltz
    Saltz
  6. O'Reilly
    O'Reilly
  7. Mao
    Mao
  8. Morris
    Morris
  9. Seidman
    Seidman
  10. Kris
    Kris

Groups

  1. Department of Medicine (753)
  2. Solid Tumor Oncology Division (541)
  3. Population Sciences Research Program (259)
  4. Survivorship Research (256)
  5. Surgery (244)
  6. Epidemiology and Biostatistics (187)
  7. Hematologic Malignancies, Division of (169)
  8. Genitourinary Oncology Service (160)
  9. Center for Hematologic Malignancies (142)
  10. Gastrointestinal Oncology Service (126)
  1. "randomized controlled trial"
Formats
  1. Journal Article (1353)
  2. Review (19)
  3. Conference Paper (17)
  4. Editorial (9)
  5. Correspondence (5)
  6. Research Letter (5)
  7. Meeting Abstract (4)
  8. Guidelines (3)
  9. Book Section (1)
Groups
  1. Department of Medicine (753)
  2. Solid Tumor Oncology Division (541)
  3. Population Sciences Research Program (259)
  4. Survivorship Research (256)
  5. Surgery (244)
  6. Epidemiology and Biostatistics (187)

More Groups

People
  1. Robert Motzer (83)
  2. Andrew Vickers (48)
  3. Larry Norton (34)
  4. Clifford Hudis (33)
  5. Leonard Saltz (32)
  6. Eileen O'Reilly (25)

More People

Years
  1. 2025 (63)
  2. 2024 (165)
  3. 2023 (110)
  4. 2022 (81)
  5. 2021 (39)
  6. 2020 (51)

More Years

Publications
  1. Journal of Clinical Oncology (164)
  2. New England Journal of Medicine (65)
  3. Lancet Oncology (46)
  4. Cancer (42)
  5. Clinical Cancer Research (42)
  6. European Urology (26)

More Publications

Publishers
  1. Elsevier Inc. (187)
  2. American Society of Clinical Oncology (170)
  3. Elsevier Science, Inc. (138)
  4. Springer (79)
  5. Lippincott Williams & Wilkins (72)
  6. Wiley Blackwell (71)

More Publishers

Results (1416)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Randomized trial of a presurgical scheduled reduced smoking intervention for patients newly diagnosed with cancer
    Journal Article

    Ostroff, J. S.; Burkhalter, J. E.; Cinciripini, P. M.; Li, Y.; Shiyko, M. P.; Lam, C. Y.; Hay, J. L.; Dhingra, L. K.; Lord-Bessen, J.; Holland, S. M.; more...
    Health Psychology (2014)

    Fulltext@MSK | Save
  • Androgen dynamics and serum PSA in patients treated with abiraterone acetate
    Journal Article

    Ryan, C. J.; Peng, W.; Kheoh, T.; Welkowsky, E.; Haqq, C. M.; Chandler, D. W.; Scher, H. I.; Molina, A.
    Prostate Cancer and Prostatic Diseases (2014)

    Fulltext@MSK | Save
  • Phase 2 trial of CPX-351, a fixed 5:1 molar ratio of cytarabine/ daunorubicin, vs cytarabine/daunorubicin in older adults with untreated AML
    Journal Article

    Lancet, J. E.; Cortes, J. E.; Hogge, D. E.; Tallman, M. S.; Kovacsovics, T. J.; Damon, L. E.; Komrokji, R.; Solomon, S. R.; Kolitz, J. E.; Cooper, M.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • Ipilimumab versus placebo after radiotherapy in patients with metastatic castration-resistant prostate cancer that had progressed after docetaxel chemotherapy (CA184-043): A multicentre, randomised, double-blind, phase 3 trial
    Journal Article

    Kwon, E. D.; Drake, C. G.; Scher, H. I.; Fizazi, K.; Bossi, A.; Van Den Eertwegh, A. J. M.; Krainer, M.; Houede, N.; Santos, R.; Mahammedi, H.; more...
    Lancet Oncology (2014)

    Fulltext@MSK | Save
  • Biomarker prediction of chemotherapy-related amenorrhea in premenopausal women with breast cancer participating in E5103
    Journal Article

    Ruddy, K. J.; O'neill, A.; Miller, K. D.; Schneider, B. P.; Baker, E.; Sparano, J. A.; Dang, C.; Northfelt, D. W.; Sledge, G. W. Jr; Partridge, A. H.
    Breast Cancer Research and Treatment (2014)

    Fulltext@MSK | Save
  • Overall survival in renal-cell carcinoma with pazopanib versus sunitinib
    Journal Article

    Motzer, R. J.; Hutson, T. E.; McCann, L.; Deen, K.; Choueiri, T. K.
    New England Journal of Medicine (2014)

    Fulltext@MSK | Save
  • Arsenic trioxide during consolidation for patients with previously untreated low/intermediate risk acute promyelocytic leukaemia may eliminate the need for maintenance therapy
    Journal Article

    Coutre, S. E.; Othus, M.; Powell, B.; Willman, C. L.; Stock, W.; Paietta, E.; Levitan, D.; Wetzler, M.; Attar, E. C.; Altman, J. K.; more...
    British Journal of Haematology (2014)

    Fulltext@MSK | Save
  • Effectiveness and cost-effectiveness of meaning-centered group psychotherapy in cancer survivors: Protocol of a randomized controlled trial
    Journal Article

    van der Spek, N.; Vos, J.; van Uden-Kraan, C. F.; Breitbart, W.; Cuijpers, P.; Knipscheer-Kuipers, K.; Willemsen, V.; Tollenaar, R. A. E. M.; van Asperen, C. J.; Verdonck-de Leeuw, I. M.
    BMC Psychiatry (2014)

    Fulltext@MSK | Save
  • Incidence and time course of everolimus-related adverse events in postmenopausal women with hormone receptor-positive advanced breast cancer: Insights from BOLERO-2
    Journal Article

    Rugo, H. S.; Pritchard, K. I.; Gnant, M.; Noguchi, S.; Piccart, M.; Hortobagyi, G.; Baselga, J.; Perez, A.; Geberth, M.; Csoszi, T.; more...
    Annals of Oncology (2014)

    Fulltext@MSK | Save
  • Dovitinib versus sorafenib for third-line targeted treatment of patients with metastatic renal cell carcinoma: An open-label, randomised phase 3 trial
    Journal Article

    Motzer, R. J.; Porta, C.; Vogelzang, N. J.; Sternberg, C. N.; Szczylik, C.; Zolnierek, J.; Kollmannsberger, C.; Rha, S. Y.; Bjarnason, G. A.; Melichar, B.; more...
    Lancet Oncology (2014)

    Fulltext@MSK | Save